Health
How worried should we be about blood clots linked to AstraZeneca, J&J vaccines? – Financial Post
ZURICH — International drug regulators have said the benefits of using COVID-19 vaccines developed by Johnson & Johnson and AstraZeneca outweigh risks as they…
Article content
ZURICH International drug regulators have said the benefits of using COVID-19 vaccines developed by Johnson & Johnson and AstraZeneca outweigh risks as they investigate reports of extremely rare, but potentially fatal blood clots.
Several EU countries have restricted their use.
Amid concerns that reports of rare side-effects could undermine vaccine confidence, experts have emphasized that clotting risks for both shots remain extremely low and the vaccines are highly effective in…
-
Noosa News18 hours agoHow Lily Steele-Park took her rapist to court and won
-
Business23 hours agoFord CEO makes stunning prediction about artificial intelligence
-
General24 hours agoRush to buy homes before rate cuts send prices soaring
-
Business21 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025